IP Library Granted Patent US 7,435,859
Granted Patent B2
US 7,435,859 · App. 10/543,549 · Granted Oct 14, 2008

Sumanene and method for manufacturing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,435,859
App. No.
10/543,549
Granted
Oct 14, 2008
Kind
B2
Abstract

The present invention provides Sumanene, its derivative and a method for manufacturing Sumanene and its derivative. As shown by a below-described scheme, benzotris(norbornadiene) (a below formula (87)) is firstly synthesized from norbornadiene (a below formula (86)). Then, the compound is subjected to a metathesis reaction so as to synthesize hexahydrosumanene (a below formula (88)), and it is dehydrogenized so as to obtain Sumanene (a below formula (84)). Thereby, Sumanene can be mass-synthesized under a moderate condition. In addition, a compound with a structure where a benzyl position of Sumanene is substituted by a N atom or an O atom can be obtained similarly, and various derivatives also can be obtained by further chemical modification of the compound. Sumanene and its derivative are suitable for electronic materials, synthesis raw materials for various kinds of fullerenes and heterofullerenes, and the like. Condition of the Reaction a) BuLi, t-BuOK, BrCH 2 CH 2 Br, THF, −78° C. to −45° C. subsequently CuI, a room temperature b) catalyst quantity of (PCy 3 ) 2 RuCl 2 ═CHPh, CH 2 ═CH 2 , toluene, 0° C. to 80° C. c) DDQ, toluene, 110° C.

Claims (12)

1. A compound represented by a below-described general formula (1), a tautomer of the compound, a stereoisomer of the compound, or a salt of any of the compound, the tautomer and the stereoisomer,

where, in the formula (1), all of the A 1 to A 6 are hydrogen atoms,

X 1 to X 3 are the same or different, and each of the X 1 to X 3 may be a methylene group (a below formula (2)) or a vinylidene group (a below formula (3)), in a case where a hydrogen atom exists on any of the X 1 to X 3 , the hydrogen atom may be substituted by a substituent,

the substituents on the X 1 to X 3 are the same or different, and each of the substituents on the X 1 to X 3 is a straight or branched chain that has a substituent and is saturated or unsaturated, a carbocyclic ring with the number of ring atoms of 3 to 20 (the ring may be a monocyclic ring or a condensed ring, may be saturated or unsaturated, and may or may not comprise a substituent), a hydroxy group or a straight or branched unsaturated hydrocarbon group with the carbon number of 2 to 6.

2. The compound, the tautomer or the compound, the stereoisomer of the compound, or the salt of any of the compound, the tautomer and the stereoisomer according to claim 1 ,

wherein, in the formula (1), each of the X 1 to X 3 is unsubstituted.

3. The compound, the tautomer of the compound, the stereoisomer of the compound, or the salt of any of the compound, the tautomer and the stereoisomer according to claim 1 ,

wherein each of the X 1 to X 3 is tbe methylene group having the formula (2).

4. A compound represented by a below formula (76) or a salt of the compound,

where, in the formula, R 1 to R 6 are the same or different, each of the R 1 to R 6 is a hydrogen atom or an aromatic hydrocarbon group,

X 11 , X 21 and X 31 are the same or different, each of the X 11 , X 21 and X 31 is a methylene group.

5. The compound or the salt of the compound according to claim 4 , wherein the R 1 to R 6 are the same or different, and each of the R 1 to R 6 is a hydrogen atom or a phenyl group.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →